vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $207.8M, roughly 1.6× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 3.4%, a 54.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $11.6M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
IDYA vs NGVC — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $335.6M |
| Net Profit | $119.2M | $11.3M |
| Gross Margin | — | 29.5% |
| Operating Margin | 52.2% | 4.4% |
| Net Margin | 57.4% | 3.4% |
| Revenue YoY | — | 1.6% |
| Net Profit YoY | 330.1% | 14.0% |
| EPS (diluted) | $1.33 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $335.6M | ||
| Q3 25 | $207.8M | $336.1M | ||
| Q2 25 | — | $328.7M | ||
| Q1 25 | — | $335.8M | ||
| Q4 24 | — | $330.2M | ||
| Q3 24 | $0 | $322.7M | ||
| Q2 24 | $0 | $309.1M | ||
| Q1 24 | $0 | $308.1M |
| Q4 25 | — | $11.3M | ||
| Q3 25 | $119.2M | $11.8M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | $-51.8M | $9.0M | ||
| Q2 24 | $-52.8M | $9.2M | ||
| Q1 24 | $-39.6M | $8.0M |
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 29.9% | ||
| Q1 25 | — | 30.3% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | — | 4.4% | ||
| Q3 25 | 52.2% | 4.6% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 5.2% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | 57.4% | 3.5% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | — | $0.49 | ||
| Q3 25 | $1.33 | $0.51 | ||
| Q2 25 | — | $0.50 | ||
| Q1 25 | — | $0.56 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | $-0.60 | $0.38 | ||
| Q2 24 | $-0.68 | $0.40 | ||
| Q1 24 | $-0.53 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $23.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $220.0M |
| Total Assets | $1.2B | $668.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.2M | ||
| Q3 25 | $786.9M | $17.1M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | — | $21.2M | ||
| Q4 24 | — | $6.3M | ||
| Q3 24 | $920.0M | $8.9M | ||
| Q2 24 | $701.7M | $13.9M | ||
| Q1 24 | $698.8M | $11.0M |
| Q4 25 | — | $220.0M | ||
| Q3 25 | $1.1B | $212.4M | ||
| Q2 25 | — | $202.5M | ||
| Q1 25 | — | $193.0M | ||
| Q4 24 | — | $181.9M | ||
| Q3 24 | $1.2B | $174.3M | ||
| Q2 24 | $931.7M | $167.8M | ||
| Q1 24 | $935.3M | $160.0M |
| Q4 25 | — | $668.6M | ||
| Q3 25 | $1.2B | $670.5M | ||
| Q2 25 | — | $659.0M | ||
| Q1 25 | — | $664.6M | ||
| Q4 24 | — | $648.9M | ||
| Q3 24 | $1.2B | $655.5M | ||
| Q2 24 | $973.7M | $654.4M | ||
| Q1 24 | $961.5M | $656.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $21.1M |
| Free Cash FlowOCF − Capex | $142.2M | $11.6M |
| FCF MarginFCF / Revenue | 68.4% | 3.4% |
| Capex IntensityCapex / Revenue | 0.0% | 2.9% |
| Cash ConversionOCF / Net Profit | 1.19× | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.1M | ||
| Q3 25 | $142.2M | $15.6M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $34.1M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | $-49.2M | $24.5M | ||
| Q2 24 | $-32.9M | $12.4M | ||
| Q1 24 | $-43.8M | $20.2M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $142.2M | $7.5M | ||
| Q2 25 | — | $-4.2M | ||
| Q1 25 | — | $27.6M | ||
| Q4 24 | — | $-6.9M | ||
| Q3 24 | $-49.7M | $18.0M | ||
| Q2 24 | $-33.9M | $3.6M | ||
| Q1 24 | $-45.1M | $9.8M |
| Q4 25 | — | 3.4% | ||
| Q3 25 | 68.4% | 2.2% | ||
| Q2 25 | — | -1.3% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 5.6% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | 1.19× | 1.32× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 2.60× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | — | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
